Argus downgraded Pfizer to Hold from Buy.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Puma Biotechnology says court denied AstraZeneca’s motion for invalidity
- Novavax (NASDAQ:NVAX) Remains Highly Speculative, Post-Pandemic
- Haleon files to sell 630M ordinary shares for holders
- Pfizer to Offload Haleon Shares Worth $2.5B
- Caribou Biosciences (NASDAQ:CRBU): Recent Price Volatility May Offer Investors an Entry Point